All that demonstrates is the inexperience of the board, they are working for free. The share price will never get to 2c again imo taking into account the selling headwind but Freddy will make bank so thats ok. Its good to see Peak taking their full entitlement in options, would it not have made sense for them to also take a cut in commission given he is also the biggest shareholder. Seems everyone takes a cut accept Peak. As for the new name, it adds to the identity crisis the company now is in the midst of under this new team. The board clearly have no conviction in this venture given the token investments, what is actually going on and who is making these decisions?
- Forums
- ASX - By Stock
- NVQ
- Ann: Notice of General Meeting/Proxy Form
Ann: Notice of General Meeting/Proxy Form, page-5
Featured News
Add NVQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.949M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 7809660 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 872476 | 3 |
Last trade - 16.12pm 03/06/2024 (20 minute delay) ? |
Featured News
NVQ (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online